ILMN
ILMN
NASDAQ · Life Sciences Tools & Services

Illumina Inc

$238.82
-0.80 (-0.33%)
Analyst Consensus
Buy
28
Analysts
High
Coverage
Buy 16 57%
Hold 9 32%
Sell 3 11%
Price Target
Analyst Price Target -29.1% upside
Low Target $114.37
Average Target $169.36
High Target $229.23
Current Price $238.82
Current
$238.82
Target
$169.36
$114.37 $169.36 avg $229.23
Scenario Analysis
Bear Case
$114.37
-52.1%
Low target
Base Case
$169.36
-29.1%
Avg target
Bull Case
$229.23
+-4.0%
High target
Risk/Reward
0.1x
Unfavorable
Price in Context
52-Week High
$246.76
-3.2% from high
52-Week Low
$88.00
+171.4% from low
50-Day SMA
$136.22
+75.3% vs SMA
200-Day SMA
$108.49
+120.1% vs SMA
RSI (14)
17.5
Oversold
Target vs 52W High
$169.36
-31.4% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 36 81% $369.21 -44.0%
DHR
Danaher Corp
Strong Buy 32 84% $158.11 -26.7%
IQV
Iqvia Holdings Inc
Strong Buy 28 82% $82.96 -69.3%
A
Agilent Technologies Inc
Strong Buy 30 77% $64.69 -60.1%
WAT
Waters Corp
Buy 31 65% $189.60 -55.3%
ILMN
Illumina Inc
Buy 28 57% $169.36 -29.1%
MTD
Mettler-Toledo International
Hold 19 53% $170.43 -88.1%
WST
West Pharmaceutical Services
Strong Buy 23 91% $136.24 -62.3%